Hide metadata

dc.date.accessioned2018-06-12T11:44:21Z
dc.date.available2018-06-12T11:44:21Z
dc.date.created2018-01-24T10:47:31Z
dc.date.issued2017
dc.identifier.citationSchjerven, Hilde Ayongaba, Etapong F. Aghajanirefah, Ali McLaughlin, Jami Cheng, Donghui Geng, Huimin Boyd, Joseph R Eggesbø, Linn Margrethe Lindeman, Ida Heath, Jessica L Park, Eugene Witte, Owen N. Smale, Stephen T. Frietze, Seth Müschen, Markus . Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre–B ALL. Journal of Experimental Medicine. 2017, 214(3), 793-814
dc.identifier.urihttp://hdl.handle.net/10852/61861
dc.description.abstractInactivation of the tumor suppressor gene encoding the transcriptional regulator Ikaros (IKZF1) is a hallmark of BCR-ABL1+ precursor B cell acute lymphoblastic leukemia (pre–B ALL). However, the mechanisms by which Ikaros functions as a tumor suppressor in pre–B ALL remain poorly understood. Here, we analyzed a mouse model of BCR-ABL1+ pre–B ALL together with a new model of inducible expression of wild-type Ikaros in IKZF1 mutant human BCR-ABL1+ pre–B ALL. We performed integrated genome-wide chromatin and expression analyses and identified Ikaros target genes in mouse and human BCR-ABL1+ pre–B ALL, revealing novel conserved gene pathways associated with Ikaros tumor suppressor function. Notably, genetic depletion of different Ikaros targets, including CTNND1 and the early hematopoietic cell surface marker CD34, resulted in reduced leukemic growth. Our results suggest that Ikaros mediates tumor suppressor function by enforcing proper developmental stage–specific expression of multiple genes through chromatin compaction at its target genes.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.titleGenetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre–B ALLen_US
dc.typeJournal articleen_US
dc.creator.authorSchjerven, Hilde
dc.creator.authorAyongaba, Etapong F.
dc.creator.authorAghajanirefah, Ali
dc.creator.authorMcLaughlin, Jami
dc.creator.authorCheng, Donghui
dc.creator.authorGeng, Huimin
dc.creator.authorBoyd, Joseph R
dc.creator.authorEggesbø, Linn Margrethe
dc.creator.authorLindeman, Ida
dc.creator.authorHeath, Jessica L
dc.creator.authorPark, Eugene
dc.creator.authorWitte, Owen N.
dc.creator.authorSmale, Stephen T.
dc.creator.authorFrietze, Seth
dc.creator.authorMüschen, Markus
cristin.unitcode185,15,29,0
cristin.unitnameInstitutt for biovitenskap
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin1550643
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Experimental Medicine&rft.volume=214&rft.spage=793&rft.date=2017
dc.identifier.jtitleJournal of Experimental Medicine
dc.identifier.volume214
dc.identifier.issue3
dc.identifier.startpage793
dc.identifier.endpage814
dc.identifier.doihttp://dx.doi.org/ 10.1084/jem.20160049
dc.identifier.urnURN:NBN:no-64468
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn0022-1007
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/61861/1/Schjerven_et-al_2017.full.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-ShareAlike 4.0 International
This item's license is: Attribution-NonCommercial-ShareAlike 4.0 International